Population Pharmacokinetics of Voriconazole and Optimization of Dosage Regimens Based on Monte Carlo Simulation in Patients With Liver Cirrhosis-Reference-Cited by-同舟云学术

Population Pharmacokinetics of Voriconazole and Optimization of Dosage Regimens Based on Monte Carlo Simulation in Patients With Liver Cirrhosis

Published:2019-12 Issue:12 Volume:108 Page:3923-3931
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Ren Qiu-xia,Li Xin-gang,Mu Jin-song,Bi Jing-feng,Du Chun-hui,Wang Yan-hong,Zhu Hong,Lv Peng,Zhao Qing-guo

Funder

Beijing Municipal Science and Technology Commission

Beijing Municipal Natural Science Foundation

Beijing Municipal Administration of Hospitals’ Youth Program

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference46 articles.

1. Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis;Horvath;Aliment Pharmacol Ther,2016

2. Fungal “colonisation” is associated with increased mortality in medical intensive care Unit patients with liver cirrhosis;Lahmer;Aliment Pharmacol Ther,2015

3. Clinical analysis of 186 severe hepatitis and cirrhosis patients with nosocomial fungal infections;Xie;J Clin Hepatol,2007

4. Voriconazole: a broad-spectrum triazole for the treatment of invasive fungal infections;Cecil;Expert Rev Hematol,2009

5. Saturated metabolism of voriconazole N-Oxidation resulting in Nonlinearity of pharmacokinetics of voriconazole at clinical doses;Takahiro;Biol Pharm Bull,2015

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of C-reactive protein on the pharmacokinetics of voriconazole in relation to the CYP2C19 genotype: a population pharmacokinetics analysis;Frontiers in Pharmacology;2024-08-20

2. Development and validation of a clinical risk score nomogram for predicting voriconazole trough concentration above 5 mg/L: a retrospective cohort study;Journal of Chemotherapy;2024-07-08

3. Pharmacogenetic implementation for CYP2C19 and pharmacokinetics of voriconazole in children with malignancy or inborn errors of immunity;Journal of Infection and Chemotherapy;2024-06

4. Remedial Dosing Recommendations for Sirolimus Delayed or Missed Dosages Caused by Poor Medication Compliance in Pediatric Tuberous Sclerosis Complex Patients;Current Pharmaceutical Design;2024-03

5. Simulation-based approaches for drug delivery systems: Navigating advancements, opportunities, and challenges;Journal of Molecular Liquids;2024-02